Your browser doesn't support javascript.
loading
Value of willingness to pay for a QALY gained in Iran; a modified chained-approach.
Jahanbin, Seyedeh-Fariba; Yusefzadeh, Hasan; Nabilou, Bahram; Alinia, Cyrus.
Affiliation
  • Jahanbin SF; Department of Health Management and Economics, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran.
  • Yusefzadeh H; Department of Health Management and Economics, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran.
  • Nabilou B; Department of Health Management and Economics, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran.
  • Alinia C; Department of Health Management and Economics, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran. siros_alinia@yahoo.com.
BMC Health Serv Res ; 21(1): 1339, 2021 Dec 14.
Article de En | MEDLINE | ID: mdl-34906099
ABSTRACT

BACKGROUND:

Due to the lack of a constant Willingness to Pay per one additional Quality Adjusted Life Years gained based on the preferences of Iran's general public, the cost-effectiveness of health system interventions is unclear and making it challenging to apply economic evaluation to health resources priority setting.

METHODS:

We have measured this cost-effectiveness threshold with the participation of 2854 individuals from five provinces, each representing an income quintile, using a modified Time Trade-Off-based Chained-Approach. In this online-based empirical survey, to extract the health utility value, participants were randomly assigned to one of two green (21121) and yellow (22222) health scenarios designed based on the earlier validated EQ-5D-3L questionnaire.

RESULTS:

Across the two health state versions, mean values for one QALY gain (rounded) ranged from $6740-$7400 and $6480-$7120, respectively, for aggregate and trimmed models, which are equivalent to 1.35-1.18 times of the GDP per capita. Log-linear Multivariate OLS regression analysis confirmed that respondents were more likely to pay if their income, disutility, and education level were higher than their counterparts.

CONCLUSIONS:

In the health system of Iran, any intervention that is with the incremental cost-effectiveness ratio, equal to and less than 7402.12 USD, will be considered cost-effective.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Revenu Type d'étude: Clinical_trials Aspects: Determinantes_sociais_saude / Patient_preference Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: BMC Health Serv Res Sujet du journal: PESQUISA EM SERVICOS DE SAUDE Année: 2021 Type de document: Article Pays d'affiliation: Iran

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Revenu Type d'étude: Clinical_trials Aspects: Determinantes_sociais_saude / Patient_preference Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: BMC Health Serv Res Sujet du journal: PESQUISA EM SERVICOS DE SAUDE Année: 2021 Type de document: Article Pays d'affiliation: Iran